News To Know

News to know

——————————————————————————

Opportunities for patients in cancer research
Studies, called clinical trials, look for new or better ways to prevent, detect, or treat cancer. The standard approaches now being used in cancer were first found to be effective through clinical trials. (more)

Check out the Sister Study
The Sister Study is the only long-term study of women aged 35 to 74 whose sister had breast cancer. It is a national study to learn how environment and genes affect the chances of getting breast cancer. In the next 3 years, 50,000 women whose sister had breast cancer, and who do not have breast cancer themselves will be asked to join the study. (more)

NCI Cancer Bulletin commemorating 20 years of CCOP success
The NCI Cancer Bulletin published a "Special Issue" devoted to the CCOP Program on September 13, 2005. The lead article is the Director's Update entitled: "For More Than 20 Years, CCOPs Define Commitment, Success." (more)
Also available at: http://www.cancer.gov/directorscorner

NCI Issues Clinical Announcement for Preferred Method of Treatment for Advanced Ovarian Cancer
The National Cancer Institute (NCI), part of the National Institutes of Health, today issued an announcement encouraging treatment with anticancer drugs via two methods, after surgery, for women with advanced ovarian cancer. The Metro-Minnesota Community Clinical Oncology Program (CCOP) participated in the NCI-supported clinical trials which led to this clinical announcement.
(more)

Initial Results of the Study of Tamoxifen and Raloxifene (STAR) Released: 04/17/06
Initial results of the Study of Tamoxifen and Raloxifene, or STAR, show that the drug
raloxifene, currently used to prevent and treat osteoporosis in postmenopausal women, works
as well as tamoxifen in reducing breast cancer risk for postmenopausal women at increased
risk of the disease.
(more)